Authors:
IRANI J
MILLET C
LEVILLAIN P
DORE B
BEGON F
AUBERT J
Citation: J. Irani et al., SERUM-TO-URINARY PROSTATE-SPECIFIC ANTIGEN RATIO - ITS IMPACT IN DISTINGUISHING PROSTATE-CANCER WHEN SERUM PROSTATE-SPECIFIC ANTIGEN LEVEL IS 4 TO 10 NG ML/, The Journal of urology, 157(1), 1997, pp. 185-188
Authors:
IRANI J
MILLET C
LEVILLAIN P
DORE B
BEGON F
AUBERT J
Citation: J. Irani et al., SERUM-TO-URINARY PROSTATE-SPECIFIC ANTIGEN RATIO - A POTENTIAL MEANS OF DISTINGUISHING BENIGN PROSTATIC HYPERPLASIA FROM PROSTATE-CANCER, European urology, 29(4), 1996, pp. 407-412
Authors:
MAHDI T
BRIZARD A
MILLET C
DORE P
TANZER J
KITZIS A
Citation: T. Mahdi et al., IN-VITRO P53 AND OR RB ANTISENSE OLIGONUCLEOTIDE TREATMENT IN ASSOCIATION WITH GROWTH-FACTORS INDUCES THE PROLIFERATION OF PERIPHERAL HEMATOPOIETIC PROGENITORS/, Journal of Cell Science, 108, 1995, pp. 1287-1293